CLINICAL TRIAL SUMMARY

MDACC Study No:GSP00-106 (clinicaltrials.gov NCT No: NCT00386906)
Title:Sentinel Lymph Node Localization and Biopsy for Conjunctival and Eyelid Melanoma
Principal Investigator:Bita Esmaeli
Treatment Agent:Biopsy; Lymphatic Mapping
Study Status:Open
Study Description:The goal of this clinical research study is to find the sentinel lymph node
(SLN) (s) and biopsy it (them) to see if the patient has small or low volume
metastatic disease that would otherwise have been missed.

Hide details for General InformationGeneral Information

Disease Group:Eye
Phase of Study:Phase I
Treatment Agents:Biopsy
Lymphatic Mapping
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:There is no hospital stay. Patients will be treated in outpatient basis and
released on the same day.
Supported By:N/A
Return Visit:At least every three months during the first year, every 6 months during the
2-5th year, and as needed.
Home Care:N/A


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Bita Esmaeli
Dept:Ophthalmology/Reconstructive & Plastic Sur
For Clinical Trial Enrollment:713-794-1247
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults